#ACR19 ABST #1513 Tofacitinib efficacy in PSA ⬇️ if BL BMI ≥ 35 . Safety consistent across all BL BMI categories. 3 CV events: non-fatal cerebrovascular accident, TIA(both Tofa 5 mg BID, BMI ≥ 30 – < 35), and artery revascularization in PBO; BMI ≥ 35 https://t.co/S1WQDRFqTv https://t.co/oEKTnwUvJP
Links:
Impact of Baseline Body Mass Index on the Efficacy and Safety of Tofacitinib in…
http://bit.ly/2pRozGk
26-11-2019